Article: Fast-lane for generics. (News in Brief).(drug patents)(Brief Article)

Article: Big pharma's bad week in Washington. (Drug ...
Chemical Week;  August 7, 2002 ;     700+ words ... ... during the next decade by eliminating mechanisms for extending drug patents. The bill was sponsored by senators Charles Schumer (D ... says you can't play games like that any more," he says. Drug patents are already treated differently from most others because ...

Article: Poverty is barrier not drug ...
Community Action;  May 17, 2004 ;     700+ words ... ... limitation on access," to drugs. This appears in a controversial study that concludes that poor countries are not harmed by drug patents, the Financial Times reported. According to Attaran only 1.4 percent of medicines designated by the World Health Organization ...

Article: Orexin-based drug.(Patents)(Brief ...
Chemistry and Industry;  November 3, 2003 ;     603 words ...Orexin receptors are involved in many biological processes, such as feeding and sleeping. This suggests that an orexin antagonist could make effective anti-obesity or anti-insomnia drugs, Orexin antagonists could also act as neuroprotectors in the event of ischemic events, such as strokes and heart

Article: AIDS and Profits.(drug patents)(Brief ...
The Nation;  April 9, 2001 ;     700+ words ..."This is not about profits and patents; it's about poverty and a devastating disease." That statement did not come from AIDS activists struggling to provide sub-Saharan Africa's 25 million HIV-positive people with access to life-extending medications. It came from the executive vice president of

Article: Controversy Continues Over Drug ...
Chemical Market Reporter;  October 4, 1999 ;     700+ words ...REIGNITING THE controversy over legislation to extend the patents on seven high-value pipeline drugs with US sales of nearly $2.5 billion, Sen. Conrad Burns (R-Mont.) has withdrawn his support for the bill just four months after he co-sponsored it. Sen. Burns changed his mind after "many meetings"

Article: Brazil Withdraws Threat To Ignore Drug ...
AIDS Weekly;  September 17, 2001 ;     700+ words ...2001 SEP 17 - (NewsRx.com & NewsRx.net) -- Brazil withdrew its threat to ignore patents and start making a generic version of a powerful AIDS drug after a Swiss pharmaceutical giant promised to slash prices by 40%. Health Minister Jose Serra, who had pledged to start making the drug Nelfinavir

Article: C[O.sub.2] dissolves ...
Chemistry and Industry;  October 6, 2003 ;     700+ words ...Cefuroxine axetil (ceftin) is a broad-spectrum antibiotic used to treat all sorts of infections. Although it is a highly effective antibiotic, it is not readily absorbed by the body. The problem is that the amorphous form of the drug readily forms a gel, preventing all the active compound from